On this episode of Stock Movers:
- CVC (CVC) shares drop after the company agreed to buy Marathon Asset Management in a cash and equity transaction with a base consideration valued at as much as $1.2 billion.
- Mankind (MNKD) shares rise after the FDA approved an update to the company’s inhaled insulin, revising recommendations for the starting mealtime dosage.
- Revolution Medicines (RVMD) shares drop on news Merck is no longer in talks to acquire biotech firm.

On this episode of Stock Movers: - CVC (CVC) shares drop after the company agreed to buy Marathon Asset Management in a cash and equity transaction with a base consideration valued at as much as $1.2 billion. - Mankind (MNKD) shares rise after the FDA approved an update to the company&rsquo;s inhaled insulin, revising recommendations for the starting mealtime dosage. - Revolution Medicines (RVMD) shares drop on news Merck is no longer in talks to acquire biotech firm.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

CVC Drops, Mankind Rises, Revolution Medicines Drops on Merck News

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d5407ca2-e26c-4185-99cd-b3de0105f552/transcript

On this episode of Stock Movers:

- Snowflake's (SNOW) shares jumped after the company raised its outlook for annual sales and touted rapid adoption of its AI-assisted coding tool. Product revenue in the year ending in January will be about $6.07 billion, beating the analysts’ average projection of $5.86 billion.

- Tyson Foods (TSN) plunged after the largest US meatpacker cut its full-year earnings forecast for the second time in a month because of increasing upheaval in the beef industry. The company's revised outlook shows annual adjusted operating income of $1.85 billion to $2.05 billion, driven by "significant margin compression" amid a severe cattle shortage. 

- Campbell's (CPB) shares slide after the food company reported a worse-than-expected decline in 4Q organic sales, and gave a bleak forecast for 1Q and fiscal 2027. The company expects elevated cost inflation, and continued weakness in its snacks division.

On this episode of Stock Movers:
- Snowflake's (SNOW) shares jumped after the company raised its outlook for annual sales and touted rapid adoption of its AI-assisted coding tool. Product revenue in the year ending in January will be about $6.07 billion, beating the analysts&rsquo; average projection of $5.86 billion.
- Tyson Foods (TSN) plunged after the largest US meatpacker cut its full-year earnings forecast for the second time in a month because of increasing upheaval in the beef industry. The company's revised outlook shows annual adjusted operating income of $1.85 billion to $2.05 billion, driven by "significant margin compression" amid a severe cattle shortage.&nbsp;
- Campbell's (CPB) shares slide after the food company reported a worse-than-expected decline in 4Q organic sales, and gave a bleak forecast for 1Q and fiscal 2027. The company expects elevated cost inflation, and continued weakness in its snacks division.

Snowflake Jumps, Tyson Foods Plunges, Campbell Slides

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/cdf889bd-dcf1-49f7-ba39-b4ba0140ace8/transcript

On this episode of Stock Movers:

- Nvidia (NVDA) shares rise. Nvidia Corp. has agreed to acquire artificial intelligence startup Hugging Face in a transaction valued at about $13 billion. The chipmaker giant said it will keep Hugging Face’s platform open and consistent with the startup’s existing practices. Nvidia Chief Executive Officer Jensen Huang is committed to helping foster so-called open source models to prevent the technology of a few large companies from dominating AI.

- Broadcom (AVGO) shares drop. A two-year forecast for AI chip sales failed to impress investors, a sign it’s still in the early stages of challenging Nvidia Corp.’s dominance. The company is seeing pressure on its gross margins and is increasingly reliant on Anthropic PBC and OpenAI as customers, who have other chip options available, including Nvidia and Advanced Micro Devices Inc. Broadcom’s custom AI semiconductor business has benefited from companies looking for ways to supplement their Nvidia-made AI chips with additional supply and variation, with chatbot makers Anthropic and OpenAI emerging as especially important clients.

- Campbell's (CPB) shares fell after the company posted its fourth straight quarterly sales decline and cut its dividend. The company unveiled a cost-savings plan that calls for $500 million in savings by fiscal 2030 to preserve margins dented by rising supply chain and tariff costs. Campbell’s expects sales to fall between 2% and 4% in fiscal 2027 and earnings per share to slide between 17% and 24% this fiscal year.

On this episode of Stock Movers: - Nvidia (NVDA) shares rise. Nvidia Corp. has agreed to acquire artificial intelligence startup Hugging Face in a transaction valued at about $13 billion. The chipmaker giant said it will keep Hugging Face&rsquo;s platform open and consistent with the startup&rsquo;s existing practices. Nvidia Chief Executive Officer Jensen Huang is committed to helping foster so-called open source models to prevent the technology of a few large companies from dominating AI. - Broadcom (AVGO) shares drop. A two-year forecast for AI chip sales failed to impress investors, a sign it&rsquo;s still in the early stages of challenging Nvidia Corp.&rsquo;s dominance. The company is seeing pressure on its gross margins and is increasingly reliant on Anthropic PBC and OpenAI as customers, who have other chip options available, including Nvidia and Advanced Micro Devices Inc. Broadcom&rsquo;s custom AI semiconductor business has benefited from companies looking for ways to supplement their Nvidia-made AI chips with additional supply and variation, with chatbot makers Anthropic and OpenAI emerging as especially important clients. - Campbell's (CPB) shares fell after the company posted its fourth straight quarterly sales decline and cut its dividend. The company unveiled a cost-savings plan that calls for $500 million in savings by fiscal 2030 to preserve margins dented by rising supply chain and tariff costs. Campbell&rsquo;s expects sales to fall between 2% and 4% in fiscal 2027 and earnings per share to slide between 17% and 24% this fiscal year.

Nvidia Rises, Broadcom Drops, Campbell's Slumps on Sales Drop

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/349ab58c-4ff3-4371-8609-b4ba00fc0807/transcript

On this episode of Stock Movers:

- Snowflake (SNOW) shares jumped. The company raised its outlook for annual sales and touted rapid adoption of its AI-assisted coding tool. Product revenue in the year ending in January will be about $6.07 billion, beating the analysts’ average projection of $5.86 billion. More than 2,000 customer accounts started using the coding assistant called CoCo during the quarter, bringing the total to 9,100.

- Hewlett Packard Enterprise (HPE) shares fell after the company reported increasing sales that didn’t meet high expectations from investors. Chief Executive Officer Antonio Neri said sales are being held back by a continued lack of components, and the company is collaborating with partners to secure additional multiyear supply agreements. HPE boosted its revenue outlook for the current fiscal year and next, with revenue expected to jump 34% to 37% in the year ending in October.

- Ultragenyx (RARE UW) shares drop. The biotech said apazunersen (GTX-102), its experimental drug to treat a rare genetic disorder, failed to meet its primary endpoint of change from baseline in Bayley-4 cognitive raw score in the Phase 3 Aspire study in Angelman syndrome patients.

On this episode of Stock Movers: - Snowflake (SNOW) shares jumped. The company raised its outlook for annual sales and touted rapid adoption of its AI-assisted coding tool. Product revenue in the year ending in January will be about $6.07 billion, beating the analysts&rsquo; average projection of $5.86 billion. More than 2,000 customer accounts started using the coding assistant called CoCo during the quarter, bringing the total to 9,100. - Hewlett Packard Enterprise (HPE) shares fell after the company reported increasing sales that didn&rsquo;t meet high expectations from investors. Chief Executive Officer Antonio Neri said sales are being held back by a continued lack of components, and the company is collaborating with partners to secure additional multiyear supply agreements. HPE boosted its revenue outlook for the current fiscal year and next, with revenue expected to jump 34% to 37% in the year ending in October. - Ultragenyx (RARE UW) shares drop. The biotech said apazunersen (GTX-102), its experimental drug to treat a rare genetic disorder, failed to meet its primary endpoint of change from baseline in Bayley-4 cognitive raw score in the Phase 3 Aspire study in Angelman syndrome patients.

Snowflake Jumps, Hewlett Packard Slides, and Ultragenyx Sinks as Rare Disorder Drug Fails Late Stage Trial

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/24510610-1555-4211-b2d1-b4ba00ebef67/transcript

CVC Drops, Mankind Rises, Revolution Medicines Drops on Merck News

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips